C vs STRO
Citigroup Inc. (C) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
C currently screens at market cap $214.73B and trailing P/E 15.5. STRO currently screens at market cap $470.8M.
Not investment advice. Open the C and STRO stock pages for the full models.
Not investment advice.